Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TKNO
HoldHot AirAlpha Teknova, Inc. · Healthcare · United States · $382M · Avg Vol: $2M/d
COMPANY DESCRIPTION
Alpha Teknova, Inc. is a leading provider of validated, research-grade reagents for life sciences applications, including genomics, proteomics, and cell culture. The company offers a broad portfolio of media, buffers, and other solutions essential for pharmaceutical and biotech R&D, as well as clinical diagnostics. Teknova holds a strong niche market position as a critical supplier of high-quality, custom-formulated reagents, supporting the accelerated pace of scientific discovery and biopharmaceutical development.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.4M | 36.7M | 37.7M | 40.5M | -0.7% | 43.7M | 45.9M | 52.3M | 13.6% |
| EPS | -1.69 | -1.16 | -0.57 | -0.32 | — | -0.31 | -0.24 | -0.19 | — |
| Shares | 28.2M | 40.8M | 53.4M | 53.6M | +90.1% | 53.7M | — | — | — |
| Debt | 42.3M | 30.5M | 30.2M | 28.3M | -12.6% | 27.4M | — | — | — |
| Equity | 99.9M | 90.0M | 82.4M | 68.8M | -11.7% | — | — | — | — |
| Op CF | -27.4M | -18.8M | -12.4M | -8.6M | — | -6.3M | — | — | — |
| Inv CF | -28.1M | -7.7M | -27.3M | 10.7M | — | — | — | — | — |
| Fin CF | 10.3M | 12.8M | 14.9M | 0.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TKNO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TKNO | Alpha Teknova, Inc.(you) | $382M | 44 | Hold |
| CL.CN | Cresco Labs Inc. | $291M | 43 | Hold |
| VREO.CN | Vireo Growth Inc. | $552M | 33 | Sell |
| EOLS | Evolus, Inc. | $587M | 55 | Hold |
| SIGA | SIGA Technologies, Inc. | $220M | 30 | Sell |
| EBS | Emergent BioSolutions Inc. | $303M | 64 | Hold |
| JUSH.CN | Jushi Holdings Inc. | $110M | 43 | Hold |
| ORGO | Organogenesis Holdings Inc. | $224M | 29 | Sell |
| ANIK | Anika Therapeutics, Inc. | $282M | 64 | Hold |
| GRIN.CN | Grown Rogue International Inc. | $111M | 46 | Hold |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.3%